2689 OLBA HEALTHCARE HOLDINGS, Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

2689

TSE Standard

OLBA HEALTHCARE HOLDINGS, Inc.

2,133

JPY

-7

(-0.33%)

Mar 13, 3:30 pm JST

13.38

USD

Mar 13, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun, 2022	107,959	2,073	2,119	1,535	252.8	60	Aug 9, 2022	J-GAAP
Jun, 2023	110,472	2,151	2,158	1,414	234.9	70	Aug 9, 2023	J-GAAP
Jun, 2024	118,564	2,226	2,244	1,500	251.7	80	Aug 9, 2024	J-GAAP
Jun, 2025	122,702	1,979	1,962	1,430	241.4	80	Aug 12, 2025	J-GAAP
Jun, 2026 Guidance	127,978	2,000	1,928	1,321	222.8	80	Aug 12, 2025	J-GAAP
YoY	+4.3%	+1.1%	-1.7%	-7.6%	-7.7%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jun, 2021	Aug 11, 2020	114,114	1,440	1,441	931	45	J-GAAP
Results	Aug 10, 2021	102,072	1,540	1,542	989	50	J-GAAP
Jun, 2022	Aug 10, 2021	Available in future release
	Apr 28, 2022
Results	Aug 9, 2022
Jun, 2023	Aug 9, 2022
	May 15, 2023
Results	Aug 9, 2023
Jun, 2024	Aug 9, 2023
	Jun 14, 2024
Results	Aug 9, 2024
Jun, 2025	Aug 9, 2024
Results	Aug 12, 2025
Jun, 2026	Aug 12, 2025	127,978	2,000	1,928	1,321	80	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jun, 2001	32,729	+4.7	Available in future release
Jun, 2002	33,484	+2.3
Jun, 2003	38,211	+14.1
Jun, 2004	37,963	-0.6
Jun, 2005	39,740	+4.7
Jun, 2006	46,176	+16.2
Jun, 2007	50,363	+9.1
Jun, 2008	54,378	+8.0
Jun, 2009	54,999	+1.1
Jun, 2010	58,863	+7.0
Jun, 2011	62,135	+5.6
Jun, 2012	74,744	+20.3
Jun, 2013	96,223	+28.7
Jun, 2014	97,137	+0.9
Jun, 2015	94,515	-2.7
Jun, 2016	101,460	+7.3
Jun, 2017	105,778	+4.3
Jun, 2018	107,663	+1.8
Jun, 2019	107,428	-0.2
Jun, 2020	107,896	+0.4
Jun, 2021	102,072	-5.4
Jun, 2022	107,959	+5.8
Jun, 2023	110,472	+2.3
Jun, 2024	118,564	+7.3
Jun, 2025	122,702	+3.5
Jun, 2026 Guidance	127,978	+4.3	2,000	+1.1	1,928	-1.7	222.8	-7.7

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Jun, 2024	118,564	2,226	1.88	13.82	3.57	2.82	251.7
Jun, 2025	122,702	1,979	1.61	12.10	3.21	2.75	241.4
Jun, 2026 Guidance	127,978	2,000	1.56	10.87	2.75	2.66	222.8

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	122,702	2,226	2,244	1,535	252.8
Fiscal Year	Jun, 2025	Jun, 2024	Jun, 2024	Jun, 2022	Jun, 2022

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2023	56,754	1,297	1,299	867	144.0	70	Aug 9, 2023	J-GAAP
Jan - Jun, 2024	61,098	1,480	1,498	1,014	170.1	80	Aug 9, 2024	J-GAAP
Jan - Jun, 2025	62,075	1,171	1,138	782	132.0	80	Aug 12, 2025	J-GAAP
Jan - Jun, 2026 Guidance	65,534	1,327	1,253	871	146.9	80	Jan 30, 2026	J-GAAP
YoY	+5.6%	+13.3%	+10.1%	+11.4%	+11.3%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Jun, 2023	2,151	-965	-659	-306	175	2,359	5.77	J-GAAP
Jun, 2024	2,226	1,411	2,084	-673	-1,089	2,681	6.20	J-GAAP
Jun, 2025	1,979	-9	1,626	-1,635	686	3,420	7.46	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jul - Dec, 2023	57,466	746	746	486	81.0	33.2	Jan 31, 2024	J-GAAP
Jul - Dec, 2024	60,627	808	824	648	109.4	42.0	Jan 31, 2025	J-GAAP
Jul - Dec, 2025	62,444	673	675	450	76.0	35.0	Jan 30, 2026	J-GAAP
YoY	+3.0%	-16.7%	-18.1%	-30.6%	-30.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	31,936	940	943	629	105.3	2.9	Apr 30, 2024	J-GAAP
Apr - Jun, 2024	29,162	540	555	385	64.6	1.9	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	29,044	279	284	168	28.4	1.0	Oct 31, 2024	J-GAAP
Oct - Dec, 2024	31,583	529	540	480	81.1	1.7	Jan 31, 2025	J-GAAP
Jan - Mar, 2025	31,853	485	461	284	48.0	1.5	Apr 30, 2025	J-GAAP
Apr - Jun, 2025	30,222	686	677	498	84.1	2.3	Aug 12, 2025	J-GAAP
Jul - Sep, 2025	30,824	258	255	166	28.1	0.8	Oct 31, 2025	J-GAAP
Oct - Dec, 2025	31,620	415	420	284	48.0	1.3	Jan 30, 2026	J-GAAP
YoY	+0.1%	-21.6%	-22.2%	-40.8%	-40.8%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	27,747	-2.3	Available in future release
Apr - Jun, 2021	24,464	+2.1
Jul - Sep, 2021	25,013	+7.5
Oct - Dec, 2021	28,017	+5.3
Jan - Mar, 2022	28,726	+3.5
Apr - Jun, 2022	26,203	+7.1
Jul - Sep, 2022	26,307	+5.2
Oct - Dec, 2022	27,411	-2.2
Jan - Mar, 2023	29,134	+1.4
Apr - Jun, 2023	27,620	+5.4
Jul - Sep, 2023	27,495	+4.5
Oct - Dec, 2023	29,971	+9.3
Jan - Mar, 2024	31,936	+9.6
Apr - Jun, 2024	29,162	+5.6
Jul - Sep, 2024	29,044	+5.6
Oct - Dec, 2024	31,583	+5.4
Jan - Mar, 2025	31,853	-0.3
Apr - Jun, 2025	30,222	+3.6
Jul - Sep, 2025	30,824	+6.1
Oct - Dec, 2025	31,620	+0.1	415	-21.6	420	-22.2	48.0	-40.8

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	31,936	940	943	629	105.3
Fiscal Year	Mar, 2024	Mar, 2024	Mar, 2024	Mar, 2024	Mar, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Jun, 2023	1,712.19	25.3	40,878	10,327	9,416	0.19	Aug 9, 2023	J-GAAP
Jun, 2024	1,922.58	26.3	43,237	11,373	10,480	0.14	Aug 9, 2024	J-GAAP
Jun, 2025	2,068.59	26.7	45,871	12,255	11,382	0.16	Aug 12, 2025	J-GAAP
Jul - Dec, 2025	ー	25.3	48,111	12,153	11,338	0.30	Jan 30, 2026	J-GAAP

OLBA HEALTHCARE HOLDINGS, Inc.(2689) Financial Results